title: [Hemodynamic effects of intravenous allapinine in patients with myocardial infarction].
abstract: Single intravenous allapinine, 30 mg, given to patients with acute myocardial infarction, including those with moderate circulatory insufficiency, fails to affect central hemodynamic parameters or has a favourable action: normalizes pulmonary diastolic pressure, cardiac index, diminishes total peripheral vascular resistance. The agent also produces a weak antihypertensive effect and increases heart rate.
authors.forename: A G
authors.initials: AG
authors.lastname: Khakimov
authors.forename: I N
authors.initials: IN
authors.lastname: Merkulova
authors.forename: D I
authors.initials: DI
authors.lastname: Chikvashvili
authors.forename: G L
authors.initials: GL
authors.lastname: Mansurova
authors.forename: M Ia
authors.initials: MIa
authors.lastname: Ruda
mesh_terms: D000157:Aconitine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000889:Anti-Arrhythmia Agents; C051402:allapinin; D000157:Aconitine
vernacular_title: Vliianie vnutrivennogo vvedeniia allapinina na gemodinamiku u bol'nykh infarktom miokarda.